{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:31:10Z","timestamp":1788849070179,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatopathies can cause major metabolic abnormalities in humans and animals. This study examined differences in serum metabolomic parameters and patterns in left-over serum samples from dogs with either congenital portosystemic shunts (cPSS, n\u2009=\u200924) or high serum liver enzyme activities (HLEA, n\u2009=\u200925) compared to control dogs (n\u2009=\u200964). A validated targeted proton nuclear magnetic resonance spectroscopy platform was used to assess 123 parameters. Principal component analysis of the serum metabolome demonstrated distinct clustering among individuals in each group, with the cluster of HLEA being broader compared to the other groups, presumably due to the wider spectrum of hepatic diseases represented in these samples. While younger and older adult control dogs had very similar metabolomic patterns and clusters, there were changes in many metabolites in the hepatopathy groups. Higher phenylalanine and tyrosine concentrations, lower branched-chained amino acids (BCAAs) concentrations, and altered fatty acid parameters were seen in cPSS dogs compared to controls. In contrast, dogs with HLEA had increased concentrations of BCAAs, phenylalanine, and various lipoproteins. Machine learning based solely on the metabolomics data showed excellent group classification, potentially identifying a novel tool to differentiate hepatopathies. The observed changes in metabolic parameters could provide invaluable insight into the pathophysiology, diagnosis, and prognosis of hepatopathies.<\/jats:p>","DOI":"10.1038\/s41598-022-09056-5","type":"journal-article","created":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T20:31:55Z","timestamp":1648585915000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Metabolomic serum abnormalities in dogs with hepatopathies"],"prefix":"10.1038","volume":"12","author":[{"given":"Carolin A.","family":"Imbery","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Dieterle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ottka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6tz","family":"Schlotterbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Lohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Giger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,29]]},"reference":[{"key":"9056_CR1","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/B978-0-12-370491-7.00013-1","volume-title":"Clinical Biochemistry of Domestic Animals","author":"BC Tennant","year":"2008","unstructured":"Tennant, B. C. & Center, S. A. Hepatic function. In Clinical Biochemistry of Domestic Animals 6th edn (ed. Kaneko, J. J.) 379\u2013412 (Elsevier Saunders, 2008).","edition":"6"},{"key":"9056_CR2","volume-title":"Zakim and Boyer's Hepatology. A Textbook of Liver Disease","year":"2012","unstructured":"Boyer, T. D. et al. (eds) Zakim and Boyer\u2019s Hepatology. A Textbook of Liver Disease 6th edn. (Saunders Elsevier, 2012).","edition":"6"},{"key":"9056_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0095-5108(18)30245-8","volume":"23","author":"JM Andres","year":"1996","unstructured":"Andres, J. M. Neonatal hepatobiliary disorders. Clin. Perinatol. 23, 321\u2013352 (1996).","journal-title":"Clin. Perinatol."},{"key":"9056_CR4","first-page":"767","volume":"23","author":"G Rocha","year":"2010","unstructured":"Rocha, G. et al. Disorders of the neonatal liver and bile ducts. Acta Med. Port. 23, 767\u2013776 (2010).","journal-title":"Acta Med. Port."},{"key":"9056_CR5","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.cvsm.2016.11.013","volume":"47","author":"P Watson","year":"2017","unstructured":"Watson, P. Canine breed-specific hepatopathies. Vet. Clin. N. Am. Small Anim. Pract. 47, 665\u2013682. https:\/\/doi.org\/10.1016\/j.cvsm.2016.11.013 (2017).","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"9056_CR6","first-page":"463","volume":"10","author":"GO Ewing","year":"1974","unstructured":"Ewing, G. O., Suter, P. F. & Bailey, C. S. Hepatic insufficiency associated with congenital anomalies of the portal vein in dogs. J. Am. Anim. Hosp. Assoc. 10, 463\u2013467 (1974).","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"9056_CR7","first-page":"211","volume":"122","author":"K Ruland","year":"2009","unstructured":"Ruland, K. et al. Portosystemic shunts in cats\u2014evaluation of six cases and a review of the literature. BMTW 122, 211\u2013218 (2009).","journal-title":"BMTW"},{"key":"9056_CR8","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1097\/mpg.0b013e31828b3750","volume":"56","author":"C Sokollik","year":"2013","unstructured":"Sokollik, C., Bandsma, R. H. J., Gana, J. C., van den Heuvel, M. & Ling, S. C. Congenital portosystemic shunt: characterization of a multisystem disease. J. Pediatr. Gastroenterol. Nutr. 56, 675\u2013681. https:\/\/doi.org\/10.1097\/mpg.0b013e31828b3750 (2013).","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"9056_CR9","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1002\/hep.30817","volume":"71","author":"A Baiges","year":"2020","unstructured":"Baiges, A. et al. Congenital extrahepatic portosystemic shunts (Abernethy Malformation): an international observational study. Hepatology 71, 658\u2013669. https:\/\/doi.org\/10.1002\/hep.30817 (2020).","journal-title":"Hepatology"},{"key":"9056_CR10","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.cvsm.2013.07.005","volume":"43","author":"SE Chapman","year":"2013","unstructured":"Chapman, S. E. & Hostutler, R. A. A laboratory diagnostic approach to hepatobiliary disease in small animals. Vet. Clin. N. Am. Small Anim. Pract. 43, 1209\u20131225. https:\/\/doi.org\/10.1016\/j.cvsm.2013.07.005 (2013).","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"9056_CR11","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1939-1676.2008.0215.x","volume":"23","author":"JH Poldervaart","year":"2009","unstructured":"Poldervaart, J. H., Favier, R. P., Penning, L. C., van den Ingh, T. S. G. A. M. & Rothuizen, J. Primary hepatitis in dogs: a retrospective review (2002\u20132006). J. Vet. Intern. Med. 23, 72\u201380. https:\/\/doi.org\/10.1111\/j.1939-1676.2008.0215.x (2009).","journal-title":"J. Vet. Intern. Med."},{"key":"9056_CR12","first-page":"1611","volume-title":"Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat","author":"S Cocker","year":"2017","unstructured":"Cocker, S. & Richter, K. Diagnostic evaluation of the liver. In Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat 8th edn (eds Ettinger, S. J. et al.) 1611\u20131621 (Elsevier Saunders, 2017).","edition":"8"},{"key":"9056_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/B978-1-4377-0881-3.00014-0","volume-title":"Zakim and Boyer's Hepatology: A Textbook of Liver Disease","author":"T Poynard","year":"2012","unstructured":"Poynard, T. & Imbert-Bismut, F. Laboratory testing for liver disease. In Zakim and Boyer\u2019s Hepatology: A Textbook of Liver Disease 6th edn (eds Boyer, T. D. et al.) 201\u2013215 (Saunders Elsevier, 2012).","edition":"6"},{"key":"9056_CR14","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2012.12.005","volume":"58","author":"M Blachier","year":"2013","unstructured":"Blachier, M., Leleu, H., Peck-Radosavljevic, M., Valla, D.-C. & Roudot-Thoraval, F. The burden of liver disease in Europe: a review of available epidemiological data. J. Hepatol. 58, 593\u2013608. https:\/\/doi.org\/10.1016\/j.jhep.2012.12.005 (2013).","journal-title":"J. Hepatol."},{"key":"9056_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.4321\/S1130-01082012000400006","volume":"104","author":"M Cerquetella","year":"2012","unstructured":"Cerquetella, M. et al. Chronic hepatitis in man and in dog: a comparative update. Rev. Esp. Enferm. Dig. 104, 203\u2013209. https:\/\/doi.org\/10.4321\/S1130-01082012000400006 (2012).","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"9056_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.rvsc.2006.11.009","volume":"83","author":"N Decaro","year":"2007","unstructured":"Decaro, N. et al. Infectious canine hepatitis: an \u201cold\u201d disease reemerging in Italy. Res. Vet. Sci. 83, 269\u2013273. https:\/\/doi.org\/10.1016\/j.rvsc.2006.11.009 (2007).","journal-title":"Res. Vet. Sci."},{"key":"9056_CR17","doi-asserted-by":"crossref","unstructured":"van den Ingh, T. S. G. A. M., van Winkle, T., Cullen, J. M., Charles, J. A. & Desmet, V. J. Morphological classification of parenchymal disorders of the canine and feline liver: 2. Hepatocellular death, hepatitis and cirrhosis. In WSAVA Standards for Clinical and Histological Diagnosis of Canine and Feline Liver Diseases 85\u2013101 (Saunders Elsevier, 2006).","DOI":"10.1016\/B978-0-7020-2791-8.50011-3"},{"key":"9056_CR18","first-page":"1628","volume-title":"Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat","author":"CB Webb","year":"2017","unstructured":"Webb, C. B. Canine inflammatory\/Infectious hepatic disease. In Textbook of Veterinary Internal Medicine: Diseases of the Dog and the Cat 8th edn (eds Ettinger, S. J. et al.) 1628\u20131633 (Elsevier Saunders, 2017).","edition":"8"},{"key":"9056_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1039\/b906712b","volume":"40","author":"WB Dunn","year":"2011","unstructured":"Dunn, W. B., Broadhurst, D. I., Atherton, H. J., Goodacre, R. & Griffin, J. L. Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy. Chem. Soc. Rev. 40, 387\u2013426. https:\/\/doi.org\/10.1039\/b906712b (2011).","journal-title":"Chem. Soc. Rev."},{"key":"9056_CR20","doi-asserted-by":"publisher","first-page":"4716","DOI":"10.1002\/pmic.200600106","volume":"6","author":"K Hollywood","year":"2006","unstructured":"Hollywood, K., Brison, D. R. & Goodacre, R. Metabolomics: current technologies and future trends. Proteomics 6, 4716\u20134723. https:\/\/doi.org\/10.1002\/pmic.200600106 (2006).","journal-title":"Proteomics"},{"key":"9056_CR21","doi-asserted-by":"publisher","first-page":"8467192","DOI":"10.1155\/2017\/8467192","volume":"2017","author":"M Yu","year":"2017","unstructured":"Yu, M., Zhu, Y., Cong, Q. & Wu, C. Metabonomics research progress on liver diseases. Can. J. Gastroenterol. Hepatol. 2017, 8467192. https:\/\/doi.org\/10.1155\/2017\/8467192 (2017).","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"9056_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3748\/wjg.v22.i1.417","volume":"22","author":"R Amathieu","year":"2016","unstructured":"Amathieu, R. et al. Nuclear magnetic resonance based metabolomics and liver diseases: recent advances and future clinical applications. World J. Gastroenterol. 22, 417\u2013426. https:\/\/doi.org\/10.3748\/wjg.v22.i1.417 (2016).","journal-title":"World J. Gastroenterol."},{"key":"9056_CR23","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11306-020-1638-7","volume":"16","author":"G Carlos","year":"2020","unstructured":"Carlos, G., Dos Santos, F. P. & Fr\u00f6ehlich, P. E. Canine metabolomics advances. Metabolomics 16, 16. https:\/\/doi.org\/10.1007\/s11306-020-1638-7 (2020).","journal-title":"Metabolomics"},{"key":"9056_CR24","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1177\/1040638720948505","volume":"32","author":"H Tran","year":"2020","unstructured":"Tran, H., McConville, M. & Loukopoulos, P. Metabolomics in the study of spontaneous animal diseases. J. Vet. Diagn. Invest. 32, 635\u2013647. https:\/\/doi.org\/10.1177\/1040638720948505 (2020).","journal-title":"J. Vet. Diagn. Invest."},{"key":"9056_CR25","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1111\/jvim.15479","volume":"33","author":"YA Lawrence","year":"2019","unstructured":"Lawrence, Y. A. et al. Untargeted metabolomic profiling of serum from dogs with chronic hepatic disease. J. Vet. Intern. Med. 33, 1344\u20131352. https:\/\/doi.org\/10.1111\/jvim.15479 (2019).","journal-title":"J. Vet. Intern. Med."},{"key":"9056_CR26","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s11306-005-0001-3","volume":"1","author":"PD Whitfield","year":"2005","unstructured":"Whitfield, P. D. et al. Metabolomics as a diagnostic tool for hepatology: validation in a naturally occurring canine model. Metabolomics 1, 215\u2013225. https:\/\/doi.org\/10.1007\/s11306-005-0001-3 (2005).","journal-title":"Metabolomics"},{"key":"9056_CR27","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/jvim.16135","volume":"35","author":"N Devriendt","year":"2021","unstructured":"Devriendt, N. et al. Plasma amino acid profiles in dogs with closed extrahepatic portosystemic shunts are only partially improved 3 months after successful gradual attenuation. J. Vet. Intern. Med. 35, 1347\u20131354. https:\/\/doi.org\/10.1111\/jvim.16135 (2021).","journal-title":"J. Vet. Intern. Med."},{"key":"9056_CR28","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.2460\/javma.2003.223.1436","volume":"223","author":"EJ Harper","year":"2003","unstructured":"Harper, E. J., Hackett, R. M., Wilkinson, J. & Heaton, P. R. Age-related variations in hematologic and plasma biochemical test results in Beagles and Labrador Retrievers. J. Am. Vet. Med. Assoc. 223, 1436\u20131442. https:\/\/doi.org\/10.2460\/javma.2003.223.1436 (2003).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"9056_CR29","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.cvsm.2006.11.009","volume":"37","author":"SA Center","year":"2007","unstructured":"Center, S. A. Interpretation of liver enzymes. Vet. Clin. N. Am. Small Anim. Pract. 37, 297\u2013333. https:\/\/doi.org\/10.1016\/j.cvsm.2006.11.009 (2007).","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."},{"key":"9056_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/vcp.12954","volume":"50","author":"C Ottka","year":"2021","unstructured":"Ottka, C., Vapalahti, K., Puurunen, J., Vahtera, L. & Lohi, H. A novel canine nuclear magnetic resonance spectroscopy-based metabolomics platform: validation and sample handling. Vet. Clin. Pathol. 50, 410\u2013426. https:\/\/doi.org\/10.1111\/vcp.12954 (2021).","journal-title":"Vet. Clin. Pathol."},{"key":"9056_CR31","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1161\/CIRCGENETICS.114.000216","volume":"8","author":"P Soininen","year":"2015","unstructured":"Soininen, P., Kangas, A. J., W\u00fcrtz, P., Suna, T. & Ala-Korpela, M. Quantitative serum nuclear magnetic resonance metabolomics in cardiovascular epidemiology and genetics. Circ. Cardiovasc. Genet. 8, 192\u2013206. https:\/\/doi.org\/10.1161\/CIRCGENETICS.114.000216 (2015).","journal-title":"Circ. Cardiovasc. Genet."},{"key":"9056_CR32","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1093\/aje\/kwx016","volume":"186","author":"P W\u00fcrtz","year":"2017","unstructured":"W\u00fcrtz, P. et al. Quantitative serum nuclear magnetic resonance metabolomics in large-scale epidemiology: a primer on -omic technologies. Am. J. Epidemiol. 186, 1084\u20131096. https:\/\/doi.org\/10.1093\/aje\/kwx016 (2017).","journal-title":"Am. J. Epidemiol."},{"key":"9056_CR33","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1039\/b910205a","volume":"134","author":"P Soininen","year":"2009","unstructured":"Soininen, P. et al. High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. Analyst. 134, 1781\u20131785. https:\/\/doi.org\/10.1039\/b910205a (2009).","journal-title":"Analyst."},{"key":"9056_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1080\/01621459.1952.10483441","volume":"47","author":"WH Kruskal","year":"1952","unstructured":"Kruskal, W. H. & Wallis, W. A. Use of ranks in one-criterion variance analysis. J. Am. Stat. Assoc. 47, 583\u2013621. https:\/\/doi.org\/10.1080\/01621459.1952.10483441 (1952).","journal-title":"J. Am. Stat. Assoc."},{"key":"9056_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1214\/aoms\/1177730491","volume":"18","author":"HB Mann","year":"1947","unstructured":"Mann, H. B. & Whitney, D. R. On a test of whether one of two random variables is stochastically larger than the other. Ann. Math. Stat. 18, 50\u201360. https:\/\/doi.org\/10.1214\/aoms\/1177730491 (1947).","journal-title":"Ann. Math. Stat."},{"key":"9056_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/01621459.1961.10482090","volume":"56","author":"OJ Dunn","year":"1961","unstructured":"Dunn, O. J. Multiple comparisons among means. J. Am. Stat. Assoc. 56, 52\u201364. https:\/\/doi.org\/10.1080\/01621459.1961.10482090 (1961).","journal-title":"J. Am. Stat. Assoc."},{"key":"9056_CR37","unstructured":"MetaboAnalyst. https:\/\/www.metaboanalyst.ca\/ (2021)."},{"key":"9056_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/0-387-25465-X_15","volume-title":"Data Mining and Knowledge Discovery Handbook","author":"L Rokach","year":"2005","unstructured":"Rokach, L. & Maimon, O. Clustering methods. In Data Mining and Knowledge Discovery Handbook (eds Maimon, O. Z. & Rokach, L.) 321\u2013352 (Springer, 2005)."},{"key":"9056_CR39","unstructured":"Witten, I. H., Frank, E., Hall, M. A. & Pal, C. J. Data Mining. Practical Machine Learning Tools and Techniques. The WEKA Workbench. Online Appendix. 4th ed. (Elsevier Reference Monographs, 2011)."},{"key":"9056_CR40","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/11564126_72","volume-title":"Knowledge Discovery in Databases: PKDD 2005. 9th European Conference on Principles and Practice of Knowledge Discovery in Databases","author":"M Sumner","year":"2005","unstructured":"Sumner, M., Frank, E. & Hall, M. Speeding up logistic model tree induction. In Knowledge Discovery in Databases: PKDD 2005. 9th European Conference on Principles and Practice of Knowledge Discovery in Databases Vol. 3721 (eds Hutchison, D. et al.) 675\u2013683 (Springer, 2005)."},{"key":"9056_CR41","first-page":"265","volume":"2","author":"K Crammer","year":"2002","unstructured":"Crammer, K. & Singer, Y. On the algorithmic implementation of multiclass kernel-based vector machines. J. Mach. Learn. Res. 2, 265\u2013292 (2002).","journal-title":"J. Mach. Learn. Res."},{"key":"9056_CR42","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF00153759","volume":"6","author":"DW Aha","year":"1991","unstructured":"Aha, D. W., Kibler, D. & Albert, M. K. Instance-based learning algorithms. Mach. Learn. 6, 37\u201366. https:\/\/doi.org\/10.1007\/BF00153759 (1991).","journal-title":"Mach. Learn."},{"key":"9056_CR43","unstructured":"Morariu, D., Cre\u021bulescu, R. & Breazu, M. The WEKA multilayer perceptron classifier. J. Adv. Stat. IT&C Econom. Life Sci. 7 (2017)."},{"key":"9056_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","volume":"45","author":"L Breiman","year":"2001","unstructured":"Breiman, L. Random forests. Mach. Learn. 45, 5\u201332. https:\/\/doi.org\/10.1023\/A:1010933404324 (2001).","journal-title":"Mach. Learn."},{"key":"9056_CR45","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2307\/1403452","volume":"69","author":"DJ Hand","year":"2001","unstructured":"Hand, D. J. & Yu, K. Idiot\u2019s Bayes: not so stupid after all?. Int. Stat. Rev. 69, 385\u2013398. https:\/\/doi.org\/10.2307\/1403452 (2001).","journal-title":"Int. Stat. Rev."},{"key":"9056_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1037\/h0071325","volume":"24","author":"H Hotelling","year":"1933","unstructured":"Hotelling, H. Analysis of a complex of statistical variables into principal components. J. Educ. Psychol. 24, 417\u2013441. https:\/\/doi.org\/10.1037\/h0071325 (1933).","journal-title":"J. Educ. Psychol."},{"key":"9056_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/978-3-540-32827-8_10","volume-title":"Handbook of Partial Least Squares","author":"S Squillacciotti","year":"2010","unstructured":"Squillacciotti, S. Prediction oriented classification in PLS path modeling. In Handbook of Partial Least Squares (eds Esposito Vinzi, V. et al.) 219\u2013233 (Springer, 2010)."},{"key":"9056_CR48","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1021\/ac051495j","volume":"78","author":"S Bijlsma","year":"2006","unstructured":"Bijlsma, S. et al. Large-scale human metabolomics studies: a strategy for data (pre-) processing and validation. Anal. Chem. 78, 567\u2013574. https:\/\/doi.org\/10.1021\/ac051495j (2006).","journal-title":"Anal. Chem."},{"key":"9056_CR49","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11306-020-01756-1","volume":"17","author":"M Masarone","year":"2021","unstructured":"Masarone, M. et al. Untargeted metabolomics as a diagnostic tool in NAFLD: discrimination of steatosis, steatohepatitis and cirrhosis. Metabolomics 17, 12. https:\/\/doi.org\/10.1007\/s11306-020-01756-1 (2021).","journal-title":"Metabolomics"},{"key":"9056_CR50","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/0022-4804(74)90053-5","volume":"16","author":"A Aguirre","year":"1974","unstructured":"Aguirre, A., Yoshimura, N., Westman, T. & Fischer, J. E. Plasma amino acids in dogs with two experimental forms of liver damage. J. Surg. Res. 16, 339\u2013345. https:\/\/doi.org\/10.1016\/0022-4804(74)90053-5 (1974).","journal-title":"J. Surg. Res."},{"key":"9056_CR51","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1097\/00000658-197803000-00024","volume":"187","author":"AR Smith","year":"1978","unstructured":"Smith, A. R. et al. Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann. Surg. 187, 343\u2013350. https:\/\/doi.org\/10.1097\/00000658-197803000-00024 (1978).","journal-title":"Ann. Surg."},{"key":"9056_CR52","doi-asserted-by":"publisher","first-page":"193","DOI":"10.5326\/0430193","volume":"43","author":"S Neumann","year":"2007","unstructured":"Neumann, S., Welling, H. & Thuere, S. Evaluation of serum L-phenylalanine concentration as indicator of liver disease in dogs: a pilot study. J. Am. Anim. Hosp. Assoc. 43, 193\u2013200. https:\/\/doi.org\/10.5326\/0430193 (2007).","journal-title":"J. Am. Anim. Hosp. Assoc."},{"key":"9056_CR53","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/0002-9610(74)90009-9","volume":"127","author":"JE Fischer","year":"1974","unstructured":"Fischer, J. E. et al. Plasma amino acids in patients with hepatic encephalopathy. Effects of amino acid infusions. Am. J. Surg. 127, 40\u201347. https:\/\/doi.org\/10.1016\/0002-9610(74)90009-9 (1974).","journal-title":"Am. J. Surg."},{"key":"9056_CR54","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1136\/gut.19.11.1068","volume":"19","author":"MY Morgan","year":"1978","unstructured":"Morgan, M. Y., Milsom, J. P. & Sherlock, S. Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut 19, 1068\u20131073. https:\/\/doi.org\/10.1136\/gut.19.11.1068 (1978).","journal-title":"Gut"},{"key":"9056_CR55","first-page":"674","volume":"75","author":"G Dam","year":"2015","unstructured":"Dam, G. et al. Muscle metabolism and whole blood amino acid profile in patients with liver disease. Scand. J. Clin. Lab. Invest. 75, 674\u2013680 (2015).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"9056_CR56","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/gut.23.5.362","volume":"23","author":"MY Morgan","year":"1982","unstructured":"Morgan, M. Y., Marshall, A. W., Milsom, J. P. & Sherlock, S. Plasma amino-acid patterns in liver disease. Gut 23, 362\u2013370. https:\/\/doi.org\/10.1136\/gut.23.5.362 (1982).","journal-title":"Gut"},{"key":"9056_CR57","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0928-4346(94)00159-3","volume":"3","author":"M Yamato","year":"1995","unstructured":"Yamato, M., Muto, Y., Yoshida, T., Kato, M. & Moriwaki, H. Clearance rate of plasma branched-chain amino acids correlates significantly with blood ammonia level in patients with liver cirrhosis. Int. Hepatol. Commun. 3, 91\u201396. https:\/\/doi.org\/10.1016\/0928-4346(94)00159-3 (1995).","journal-title":"Int. Hepatol. Commun."},{"key":"9056_CR58","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1172\/JCI105690","volume":"46","author":"RJ Levine","year":"1967","unstructured":"Levine, R. J. & Conn, H. O. Tyrosine metabolism in patients with liver disease. J. Clin. Invest. 46, 2012\u20132020. https:\/\/doi.org\/10.1172\/JCI105690 (1967).","journal-title":"J. Clin. Invest."},{"key":"9056_CR59","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s11011-013-9428-9","volume":"29","author":"M Hole\u010dek","year":"2014","unstructured":"Hole\u010dek, M. Evidence of a vicious cycle in glutamine synthesis and breakdown in pathogenesis of hepatic encephalopathy-therapeutic perspectives. Metab. Brain Dis. 29, 9\u201317. https:\/\/doi.org\/10.1007\/s11011-013-9428-9 (2014).","journal-title":"Metab. Brain Dis."},{"key":"9056_CR60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/s0140-6736(71)92048-4","volume":"298","author":"J Fischer","year":"1971","unstructured":"Fischer, J. & Baldessarini, R. False neurotransmitters and hepatic failure. Lancet 298, 75\u201380. https:\/\/doi.org\/10.1016\/s0140-6736(71)92048-4 (1971).","journal-title":"Lancet"},{"key":"9056_CR61","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/BF02674674","volume":"12","author":"J Butterworth","year":"1997","unstructured":"Butterworth, J., Gregory, C. R. & Aronson, L. R. Selective alterations of cerebrospinal fluid amino acids in dogs with congenital portosystemic shunts. Metab. Brain Dis. 12, 299\u2013306. https:\/\/doi.org\/10.1007\/BF02674674 (1997).","journal-title":"Metab. Brain Dis."},{"key":"9056_CR62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nutres.2019.11.009","volume":"74","author":"K Katayama","year":"2020","unstructured":"Katayama, K. Zinc and protein metabolism in chronic liver diseases. Nutr. Res. 74, 1\u20139. https:\/\/doi.org\/10.1016\/j.nutres.2019.11.009 (2020).","journal-title":"Nutr. Res."},{"key":"9056_CR63","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3109\/00365513.2013.773591","volume":"73","author":"JB Jeppesen","year":"2013","unstructured":"Jeppesen, J. B., Mortensen, C., Bendtsen, F. & M\u00f8ller, S. Lactate metabolism in chronic liver disease. Scand. J. Clin. Lab. Invest. 73, 293\u2013299. https:\/\/doi.org\/10.3109\/00365513.2013.773591 (2013).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"9056_CR64","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1136\/gut.16.2.144","volume":"16","author":"CO Record","year":"1975","unstructured":"Record, C. O., Iles, R. A., Cohen, R. D. & Williams, R. Acid-base and metabolic disturbances in fulminant hepatic failure. Gut 16, 144\u2013149. https:\/\/doi.org\/10.1136\/gut.16.2.144 (1975).","journal-title":"Gut"},{"key":"9056_CR65","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0168-8278(85)80778-9","volume":"1","author":"D Bihari","year":"1985","unstructured":"Bihari, D., Gimson, A. E., Lindridge, J. & Williams, R. Lactic acidosis in fulminant hepatic failure. Some aspects of pathogenesis and prognosis. J. Hepatol. 1, 405\u2013416. https:\/\/doi.org\/10.1016\/S0168-8278(85)80778-9 (1985).","journal-title":"J. Hepatol."},{"key":"9056_CR66","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/s0168-8278(00)80126-9","volume":"33","author":"JO Clemmesen","year":"2000","unstructured":"Clemmesen, J. O., H\u00f8y, C.-E., Kondrup, J. & Ott, P. Splanchnic metabolism of fuel substrates in acute liver failure. J. Hepatol. 33, 941\u2013948. https:\/\/doi.org\/10.1016\/s0168-8278(00)80126-9 (2000).","journal-title":"J. Hepatol."},{"key":"9056_CR67","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1097\/00003246-200111000-00011","volume":"29","author":"ND Murphy","year":"2001","unstructured":"Murphy, N. D. et al. Liver and intestinal lactate metabolism in patients with acute hepatic failure undergoing liver transplantation. Crit. Care Med. 29, 2111\u20132118. https:\/\/doi.org\/10.1097\/00003246-200111000-00011 (2001).","journal-title":"Crit. Care Med."},{"key":"9056_CR68","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1016\/j.febslet.2013.06.019","volume":"587","author":"B van de Wier","year":"2013","unstructured":"van de Wier, B. et al. Elevated citrate levels in non-alcoholic fatty liver disease: the potential of citrate to promote radical production. FEBS Lett. 587, 2461\u20132466. https:\/\/doi.org\/10.1016\/j.febslet.2013.06.019 (2013).","journal-title":"FEBS Lett."},{"key":"9056_CR69","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/ajg.2014.370","volume":"110","author":"CJ Sands","year":"2015","unstructured":"Sands, C. J. et al. Metabolic phenotyping for enhanced mechanistic stratification of chronic hepatitis C-induced liver fibrosis. Am. J. Gastroenterol. 110, 159\u2013169. https:\/\/doi.org\/10.1038\/ajg.2014.370 (2015).","journal-title":"Am. J. Gastroenterol."},{"key":"9056_CR70","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1097\/01.CCM.0000084871.76568.E6","volume":"31","author":"L Kramer","year":"2003","unstructured":"Kramer, L. et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit. Care Med. 31, 2450\u20132455. https:\/\/doi.org\/10.1097\/01.CCM.0000084871.76568.E6 (2003).","journal-title":"Crit. Care Med."},{"key":"9056_CR71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s1388-1981(01)00117-2","volume":"1532","author":"H Yamashita","year":"2001","unstructured":"Yamashita, H., Kaneyuki, T. & Tagawa, K. Production of acetate in the liver and its utilization in peripheral tissues. Biochim. Biophys. Acta 1532, 79\u201387. https:\/\/doi.org\/10.1016\/s1388-1981(01)00117-2 (2001).","journal-title":"Biochim. Biophys. Acta"},{"key":"9056_CR72","first-page":"145","volume-title":"Tietz Textbook of Clinical Chemistry and Molecular Diagnostics","author":"DM Haverstick","year":"2013","unstructured":"Haverstick, D. M. & Groszbach, A. R. Specimen collection and processing. In Tietz Textbook of Clinical Chemistry and Molecular Diagnostics 5th edn (eds Burtis, C. A. & Ashwood Edward, R.) 145\u2013162 (Saunders Elsevier, 2013).","edition":"5"},{"key":"9056_CR73","doi-asserted-by":"publisher","first-page":"18175","DOI":"10.1038\/srep18175","volume":"5","author":"R Gao","year":"2015","unstructured":"Gao, R. et al. Serum metabolomics to identify the liver disease-specific biomarkers for the progression of hepatitis to hepatocellular carcinoma. Sci. Rep. 5, 18175. https:\/\/doi.org\/10.1038\/srep18175 (2015).","journal-title":"Sci. Rep."},{"key":"9056_CR74","doi-asserted-by":"crossref","unstructured":"Ylikahri, R. Metabolic and nutritional aspects of xylitol. In: Advances in Food Research, Vol. 25. 159\u2013180 (Elsevier, 1979).","DOI":"10.1016\/S0065-2628(08)60237-2"},{"key":"9056_CR75","doi-asserted-by":"publisher","first-page":"221","DOI":"10.3390\/vetsci8100221","volume":"8","author":"SN Assawarachan","year":"2021","unstructured":"Assawarachan, S. N., Chuchalermporn, P., Maneesaay, P. & Thengchaisri, N. Changes in serum lipid profiles among canine patients suffering from chronic hepatitis. Vet. Sci. 8, 221. https:\/\/doi.org\/10.3390\/vetsci8100221 (2021).","journal-title":"Vet. Sci."},{"key":"9056_CR76","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/jvim.14866","volume":"32","author":"JL Harrison","year":"2018","unstructured":"Harrison, J. L., Turek, B. J., Brown, D. C., Bradley, C. & Callahan Clark, J. Cholangitis and cholangiohepatitis in dogs: a descriptive study of 54 cases based on histopathologic diagnosis (2004\u20132014). J. Vet. Intern. Med. 32, 172\u2013180. https:\/\/doi.org\/10.1111\/jvim.14866 (2018).","journal-title":"J. Vet. Intern. Med."},{"key":"9056_CR77","doi-asserted-by":"publisher","first-page":"e0187315","DOI":"10.1371\/journal.pone.0187315","volume":"12","author":"S Lee","year":"2017","unstructured":"Lee, S., Kweon, O.-K. & Kim, W. H. Associations between serum leptin levels, hyperlipidemia, and cholelithiasis in dogs. PLoS ONE 12, e0187315. https:\/\/doi.org\/10.1371\/journal.pone.0187315 (2017).","journal-title":"PLoS ONE"},{"key":"9056_CR78","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1748-5827.1993.tb03519.x","volume":"34","author":"TDG Watson","year":"1993","unstructured":"Watson, T. D. G. & Barrie, J. Lipoprotein metabolism and hyperlipidaemia in the dog and cat: a review. J. Small Anim. Pract. 34, 479\u2013487. https:\/\/doi.org\/10.1111\/j.1748-5827.1993.tb03519.x (1993).","journal-title":"J. Small Anim. Pract."},{"key":"9056_CR79","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1515\/cclm.1996.34.9.701","volume":"34","author":"MI Arranz","year":"1996","unstructured":"Arranz, M. I. et al. Fatty acid composition of lipoprotein lipids in hepatobiliary diseases. Eur. J. Clin. Chem. Clin. Biochem. 34, 701\u2013709. https:\/\/doi.org\/10.1515\/cclm.1996.34.9.701 (1996).","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"9056_CR80","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/s1542-3565(04)00622-6","volume":"3","author":"A Habib","year":"2005","unstructured":"Habib, A. et al. High-density lipoprotein cholesterol as an indicator of liver function and prognosis in noncholestatic cirrhotics. Clin. Gastroenterol. Hepatol. 3, 286\u2013291. https:\/\/doi.org\/10.1016\/s1542-3565(04)00622-6 (2005).","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"9056_CR81","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1186\/s12876-020-01522-6","volume":"20","author":"R Cheng","year":"2020","unstructured":"Cheng, R. et al. High-density lipoprotein cholesterol is a predictor of survival in cirrhotic patients with acute gastrointestinal bleeding: a retrospective study. BMC Gastroenterol. 20, 381. https:\/\/doi.org\/10.1186\/s12876-020-01522-6 (2020).","journal-title":"BMC Gastroenterol."},{"key":"9056_CR82","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jhep.2020.01.026","volume":"73","author":"M Trieb","year":"2020","unstructured":"Trieb, M. et al. HDL-related biomarkers are robust predictors of survival in patients with chronic liver failure. J. Hepatol. 73, 113\u2013120. https:\/\/doi.org\/10.1016\/j.jhep.2020.01.026 (2020).","journal-title":"J. Hepatol."},{"key":"9056_CR83","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1021\/pr200265z","volume":"10","author":"R Amathieu","year":"2011","unstructured":"Amathieu, R. et al. Metabolomic approach by 1H NMR spectroscopy of serum for the assessment of chronic liver failure in patients with cirrhosis. J. Proteome Res. 10, 3239\u20133245. https:\/\/doi.org\/10.1021\/pr200265z (2011).","journal-title":"J. Proteome Res."},{"key":"9056_CR84","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/0026-0495(68)90012-7","volume":"17","author":"R Caren","year":"1968","unstructured":"Caren, R. & Corbo, L. The origin of plasma arachidonic acid in dogs. Metabolism 17, 1043\u20131050. https:\/\/doi.org\/10.1016\/0026-0495(68)90012-7 (1968).","journal-title":"Metabolism"},{"key":"9056_CR85","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3164\/jcbn.33.1","volume":"33","author":"TY Abdel-Ghaffar","year":"2003","unstructured":"Abdel-Ghaffar, T. Y., Amin, M., Abdel Rasheed, M. & Fouad, H. H. Essential fatty acids status in infants and children with chronic liver disease. J. Clin. Biochem. Nutr. 33, 1\u20136. https:\/\/doi.org\/10.3164\/jcbn.33.1 (2003).","journal-title":"J. Clin. Biochem. Nutr."},{"key":"9056_CR86","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/s0899-9007(96)00122-0","volume":"12","author":"E Cabr\u00e9","year":"1996","unstructured":"Cabr\u00e9, E. & Gassull, M. A. Polyunsaturated fatty acid deficiency in liver diseases: pathophysiological and clinical significance. Nutrition 12, 542\u2013548. https:\/\/doi.org\/10.1016\/s0899-9007(96)00122-0 (1996).","journal-title":"Nutrition"},{"key":"9056_CR87","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","volume":"61","author":"JD Otvos","year":"2015","unstructured":"Otvos, J. D. et al. GlycA: a composite nuclear magnetic resonance biomarker of systemic inflammation. Clin. Chem. 61, 714\u2013723. https:\/\/doi.org\/10.1373\/clinchem.2014.232918 (2015).","journal-title":"Clin. Chem."},{"key":"9056_CR88","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/0014-5793(87)80168-0","volume":"215","author":"JD Bell","year":"1987","unstructured":"Bell, J. D., Brown, J., Nicholson, J. K. & Sadler, P. J. Assignment of resonances for \u2018acute-phase\u2019 glycoproteins in high resolution proton NMR spectra of human blood plasma. FEBS Lett. 215, 311\u2013315. https:\/\/doi.org\/10.1016\/0014-5793(87)80168-0 (1987).","journal-title":"FEBS Lett."},{"key":"9056_CR89","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1111\/eci.12481","volume":"45","author":"EG Gruppen","year":"2015","unstructured":"Gruppen, E. G., Connelly, M. A., Otvos, J. D., Bakker, S. J. L. & Dullaart, R. P. F. A novel protein glycan biomarker and LCAT activity in metabolic syndrome. Eur. J. Clin. Invest. 45, 850\u2013859. https:\/\/doi.org\/10.1111\/eci.12481 (2015).","journal-title":"Eur. J. Clin. Invest."},{"key":"9056_CR90","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.clinbiochem.2015.05.001","volume":"48","author":"RPF Dullaart","year":"2015","unstructured":"Dullaart, R. P. F., Gruppen, E. G., Connelly, M. A., Otvos, J. D. & Lefrandt, J. D. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin\/adiponectin ratio than to glucose tolerance status. Clin. Biochem. 48, 811\u2013814. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.05.001 (2015).","journal-title":"Clin. Biochem."},{"key":"9056_CR91","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s10753-014-0107-8","volume":"38","author":"K Dungan","year":"2015","unstructured":"Dungan, K., Binkley, P. & Osei, K. GlycA is a novel marker of inflammation among non-critically ill hospitalized patients with type 2 diabetes. Inflammation 38, 1357\u20131363. https:\/\/doi.org\/10.1007\/s10753-014-0107-8 (2015).","journal-title":"Inflammation"},{"key":"9056_CR92","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13075-015-0646-x","volume":"17","author":"MJ Ormseth","year":"2015","unstructured":"Ormseth, M. J. et al. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis. Arthritis Res. Ther. 17, 117. https:\/\/doi.org\/10.1186\/s13075-015-0646-x (2015).","journal-title":"Arthritis Res. Ther."},{"key":"9056_CR93","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jacl.2020.07.012","volume":"14","author":"JA Levine","year":"2020","unstructured":"Levine, J. A. et al. Associations of GlycA and high-sensitivity C-reactive protein with measures of lipolysis in adults with obesity. J. Clin. Lipidol. 14, 667\u2013674. https:\/\/doi.org\/10.1016\/j.jacl.2020.07.012 (2020).","journal-title":"J. Clin. Lipidol."},{"key":"9056_CR94","doi-asserted-by":"publisher","first-page":"e0139057","DOI":"10.1371\/journal.pone.0139057","volume":"10","author":"EG Gruppen","year":"2015","unstructured":"Gruppen, E. G. et al. GlycA, a pro-Inflammatory glycoprotein biomarker, and incident cardiovascular disease: relationship with c-reactive protein and renal function. PLoS ONE 10, e0139057. https:\/\/doi.org\/10.1371\/journal.pone.0139057 (2015).","journal-title":"PLoS ONE"},{"key":"9056_CR95","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cca.2015.11.001","volume":"452","author":"MA Connelly","year":"2016","unstructured":"Connelly, M. A. et al. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study. Clin. Chim. Acta 452, 10\u201317. https:\/\/doi.org\/10.1016\/j.cca.2015.11.001 (2016).","journal-title":"Clin. Chim. Acta"},{"key":"9056_CR96","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3390\/jcm9020354","volume":"9","author":"R Fuertes-Mart\u00edn","year":"2020","unstructured":"Fuertes-Mart\u00edn, R., Correig, X., Vallv\u00e9, J.-C. & Amig\u00f3, N. Human serum\/plasma glycoprotein analysis by 1H-NMR, an emerging method of inflammatory assessment. J. Clin. Med. 9, 354. https:\/\/doi.org\/10.3390\/jcm9020354 (2020).","journal-title":"J. Clin. Med."},{"key":"9056_CR97","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s11306-021-01803-5","volume":"17","author":"C Ottka","year":"2021","unstructured":"Ottka, C., Weber, C., M\u00fcller, E. & Lohi, H. Serum NMR metabolomics uncovers multiple metabolic changes in phenobarbital-treated dogs. Metabolomics 17, 54. https:\/\/doi.org\/10.1007\/s11306-021-01803-5 (2021).","journal-title":"Metabolomics"},{"key":"9056_CR98","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1939-165X.2009.00181.x","volume":"39","author":"M Yuki","year":"2010","unstructured":"Yuki, M., Itoh, H. & Takase, K. Serum alpha-1-acid glycoprotein concentration in clinically healthy puppies and adult dogs and in dogs with various diseases. Vet. Clin. Pathol. 39, 65\u201371. https:\/\/doi.org\/10.1111\/j.1939-165X.2009.00181.x (2010).","journal-title":"Vet. Clin. Pathol."},{"key":"9056_CR99","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0021-9975(98)80046-7","volume":"119","author":"M Andersson","year":"1998","unstructured":"Andersson, M., Stenstr\u00f6m, M., Vatne, M., Sevelius, E. & J\u00f6nsson, L. Disease-related variations of the glycosylation of haptoglobin in the dog. J. Comp. Pathol. 119, 227\u2013238. https:\/\/doi.org\/10.1016\/S0021-9975(98)80046-7 (1998).","journal-title":"J. Comp. Pathol."},{"key":"9056_CR100","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1136\/vr.101306","volume":"173","author":"K Crawford","year":"2013","unstructured":"Crawford, K. et al. Serum haptoglobin concentrations in dogs with liver disease. Vet. Rec. 173, 579. https:\/\/doi.org\/10.1136\/vr.101306 (2013).","journal-title":"Vet. Rec."},{"key":"9056_CR101","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cvsm.2009.02.004","volume":"39","author":"AC Berent","year":"2009","unstructured":"Berent, A. C. & Tobias, K. M. Portosystemic vascular anomalies. Vet. Clin. N. Am. Small Anim. Pract. 39, 513\u2013541. https:\/\/doi.org\/10.1016\/j.cvsm.2009.02.004 (2009).","journal-title":"Vet. Clin. N. Am. Small Anim. Pract."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09056-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09056-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T00:59:37Z","timestamp":1669337977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-09056-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,29]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["9056"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-09056-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,29]]},"assertion":[{"value":"8 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted as part of Carolin A. Imbery\u2019s doctoral thesis at the University of Z\u00fcrich, Switzerland. Carolin A. Imbery and Corinna Weber are employed, and Elisabeth M\u00fcller is the owner and executive director of Laboklin GmbH & Co. KG, Bad Kissingen, Germany. Laboklin offers a variety of diagnostic laboratory tests for animals. Claudia Ottka is employed, and Hannes Lohi is the board director of PetMeta Labs Oy, Helsinki, Finland, which provides NMR metabolomic testing for dogs. Urs Giger has been a scientific advisor to Laboklin. Frank Dieterle\u00a0is the CEO of Dieterle Life Sciences Consulting, Binningen, Switzerland. G\u00f6tz Schlotterbeck declares no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5329"}}